Interim results from the Phase II COURAGE trial show that combining semaglutide with anti-GDF8 antibody trevogrumab preserves ...

OKC's Mark Daigneault knows what it takes to win championships. His wife has won a ton of them What is a good credit score?

Protective association seen between GLP-1 receptor agonist use and colon and rectal cancers in adults with obesity and diabetes ...

Obesity prevalence is rapidly increasing among older adults, posing significant health challenges and emphasizing the need ...

A new report from health data firm Truveta shows there was 50 per cent increase in American teenagers using the weight-loss drug Wegovy, particularly those living with obesity.

Regeneron's trevogrumab trial has proved, overall, successful - potentially providing a solution to a reported Wegovy side ...

Hims agreed to buy private European telehealth firm Zava, which operates in the U.K., Germany, France, and Ireland.

Company enters option agreement with JiKang Therapeutics to in-license novel APJ agonist antibody EMERYVILLE, Calif., June 03, 2025 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. ("BioAge", "the Company"), a ...

American teens are increasingly turning to the weight-loss drug Wegovy as more families and their doctors gain confidence in ...

Financial Stability: Eli Lilly's balance sheet is more robust, with debt making up only 4% of equity, considerably less than ...

A study of real-world and virtual patients suggests that a less frequent dosing of glucagon-like peptide 1 receptor agonists ...

New data indicates that American teenagers are increasingly using the weight-loss drug Wegovy, as confidence in its use for ...